Edmonton, Canada

Clinton G Chin


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1977-1978

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Clinton G Chin: Innovator in Pharmaceutical Chemistry

Introduction

Clinton G Chin is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with potential applications in antibiotic treatments. With a total of 3 patents to his name, Chin's work exemplifies innovation and dedication to advancing medical science.

Latest Patents

Chin's latest patents include groundbreaking inventions such as "Thiazoleneazetidinones from dithiazeneazetidinones." This patent describes an improved process for preparing 4-thia-2,6-diazabicyclo[3,2,0]hept-2-ene-7-ones, which are useful intermediates in the preparation of certain 3-cephems. Another significant patent is related to "Thioamides of beta-lactam antibiotics," which focuses on compounds that hold promise for enhancing antibiotic efficacy.

Career Highlights

Chin is associated with Connlab Holdings Limited, where he has been instrumental in driving research and development efforts. His innovative approaches have led to advancements in pharmaceutical formulations and processes, contributing to the broader field of medicinal chemistry.

Collaborations

Chin has collaborated with esteemed colleagues such as Ronald G Micetich and Robert B Morin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their collective work.

Conclusion

Clinton G Chin's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in antibiotic development and medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…